Literature DB >> 12554742

Prothymosin alpha is processed to thymosin alpha 1 and thymosin alpha 11 by a lysosomal asparaginyl endopeptidase.

Concepción S Sarandeses1, Guillermo Covelo, Cristina Díaz-Jullien, Manuel Freire.   

Abstract

Thymosin alpha(1) (T alpha(1)) and thymosin T alpha(11) (T alpha(11)) are polypeptides with immunoregulatory properties first isolated from thymic extracts, corresponding to the first 28 and 35 amino acid residues, respectively, of prothymosin alpha (ProT alpha), a protein involved in chromatin remodeling. It has been widely supposed that these polypeptides are not natural products of the in vivo processing of ProT alpha, since neither was found in extracts in which proteolysis was prevented. Here we show that a lysosomal asparaginyl endopeptidase is able to process ProT alpha to generate T alpha(1) and T alpha(11). In view of its catalytic properties and structural and immunological analyses, this protease was identified as mammalian legumain. It selectively cleaves some of the asparaginyl-glycine residues in the ProT alpha sequence; specifically, Asn(28)-Gly(29) and Asn(35)-Gly(36) residues are cleaved with similar efficiency in vitro to generate T alpha(1) and T alpha(11), respectively. By contrast T alpha(1) is the main product detected in vivo, free in the cytosol, at concentrations similar to that of ProT alpha. The data here reported demonstrate that T alpha(1) is not an artifact but rather is naturally present in diverse mammalian tissues and raise the possibility that it has a functional role.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554742     DOI: 10.1074/jbc.M213005200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages.

Authors:  Arevik Mosoian; Avelino Teixeira; Anthony A High; Robert E Christian; Donald F Hunt; Jeffrey Shabanowitz; Xinyan Liu; Mary Klotman
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases.

Authors:  F Pica; M S Chimenti; R Gaziano; C Buè; I A Casalinuovo; P Triggianese; P Conigliaro; D Di Carlo; V Cordero; G Adorno; A Volpi; R Perricone; E Garaci
Journal:  Clin Exp Immunol       Date:  2016-08-01       Impact factor: 4.330

3.  Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage.

Authors:  Lixia Zhao; Tian Hua; Christopher Crowley; Heng Ru; Xiangmin Ni; Neil Shaw; Lianying Jiao; Wei Ding; Lu Qu; Li-Wei Hung; Wei Huang; Lei Liu; Keqiang Ye; Songying Ouyang; Genhong Cheng; Zhi-Jie Liu
Journal:  Cell Res       Date:  2014-01-10       Impact factor: 25.617

4.  Activation of IKK by thymosin alpha1 requires the TRAF6 signalling pathway.

Authors:  Ping Zhang; Justin Chan; Ana-Maria Dragoi; Xing Gong; Stanimir Ivanov; Zhi-Wei Li; Tsung-Hsien Chuang; Tsheng Chuang; Cynthia Tuthill; Yinsheng Wan; Michael Karin; Wen-Ming Chu
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

5.  The asparaginyl endopeptidase legumain after experimental stroke.

Authors:  Taku Ishizaki; Agnes Erickson; Enida Kuric; Mehrdad Shamloo; Ikuko Hara-Nishimura; Ana Rita Lourenço Inácio; Tadeusz Wieloch; Karsten Ruscher
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

Review 6.  Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases.

Authors:  Zhentao Zhang; Manling Xie; Keqiang Ye
Journal:  Expert Opin Ther Targets       Date:  2016-05-13       Impact factor: 6.902

7.  Immunocytological and preliminary immunohistochemical studies of prothymosin alpha, a human cancer-associated polypeptide, with a well-characterized polyclonal antibody.

Authors:  Persefoni Klimentzou; Angeliki Drougou; Birgit Fehrenbacher; Martin Schaller; Wolfgang Voelter; Calypso Barbatis; Maria Paravatou-Petsotas; Evangelia Livaniou
Journal:  J Histochem Cytochem       Date:  2008-08-18       Impact factor: 2.479

8.  Expression and hydroxylamine cleavage of thymosin alpha 1 concatemer.

Authors:  Liang Zhou; Zong-Teng Lai; Min-Kan Lu; Xing-Guo Gong; Yi Xie
Journal:  J Biomed Biotechnol       Date:  2008

9.  Generation of mature Nα-terminal acetylated thymosin α 1 by cleavage of recombinant prothymosin α.

Authors:  Bo Liu; Xin Gong; Shaohong Chang; Peng Sun; Jun Wu
Journal:  ScientificWorldJournal       Date:  2013-10-28

10.  Subcellular dissemination of prothymosin alpha at normal physiology: immunohistochemical vis-a-vis western blotting perspective.

Authors:  Caroline Mwendwa Kijogi; Christopher Khayeka-Wandabwa; Keita Sasaki; Yoshimasa Tanaka; Hiroshi Kurosu; Hayato Matsunaga; Hiroshi Ueda
Journal:  BMC Physiol       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.